Advertisement
Advertisement
Balisa

Balisa

bilastine

Manufacturer:

Sriprasit Pharma

Distributor:

SPS Medical

Marketer:

SPS Medical
Concise Prescribing Info
Contents
Bilastine
Indications/Uses
Symptomatic treatment of allergic rhino-conjunctivitis (seasonal & perennial) & urticaria in adults & adolescents ≥12 yr.
Dosage/Direction for Use
Adult & adolescent ≥12 yr 20 mg (1 tab) once daily.
Administration
Should be taken on an empty stomach.
Contraindications
Special Precautions
Discontinue treatment after symptoms have resolved & reinitiate upon reappearance for seasonal allergic rhinitis. Avoid coadministration w/ P-gp inhibitors eg, ketoconazole, erythromycin, cyclosporine, ritonavir or diltiazem in patients w/ moderate or severe renal impairment. May affect ability to drive & use machines. Avoid use during pregnancy. Lactation. Not to be used in childn <6 yr weighing <20 kg. Renally & hepatically impaired childn.
Adverse Reactions
Headache. Adult & adolescent: Somnolence. Paed: Rhinitis; allergic conjunctivitis; abdominal/upper abdominal pain.
Drug Interactions
Reduced oral bioavailability w/ food; grapefruit juice. Decreased plasma conc w/ OATP1A2 substrates or inhibitors eg, ritonavir or rifampicin. Increased AUC & Cmax w/ ketoconazole or erythromycin. Potential to increase plasma conc w/ P-gp substrates or inhibitors eg, cyclosporine. Increased Cmax w/ diltiazem.
MIMS Class
Antihistamines & Antiallergics
ATC Classification
R06AX29 - bilastine ; Belongs to the class of other antihistamines for systemic use.
Presentation/Packing
Form
Balisa tab 20 mg
Packing/Price
1 × 10's;5 × 10's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement